Last Price Today's Change   Day's Range   Trading Volume
0.005   0.00 (0.00%)  0.005 - 0.005  988,830


Avg Volume (4 weeks):0
4 Weeks Range:0.005 - 0.005
4 Weeks Price Volatility (%):
52 Weeks Range:0.001 - 0.007
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Factor Therapeutics Limited, formerly Tissue Therapies Limited, is a biotechnology company. The Company's principal activities include the development and commercialization of its intellectual property in wound care. The Company's lead program, VF-001, is a biologic product for wound care. VF-001 can be used in conjunction with standard care compression bandaging in the community setting. VF-001 is a fusion protein between a truncated vitronectin peptide and Insulin-like growth factor 1(IGF-1). The initial indication for VF-001 is for Venous Leg Ulcers (VLUs). The Company also has other programs in early development to address other wound applications, as well as new products in the ocular wound care space. Its pipeline includes VF-002, a viscous product to assess burn potential, particularly mucosal burns from radiation therapy, and VF-003 and VF-004, for growth in eye procedures/use of glaucoma stents, reduction of fibrosis and minimization of negative effects of ocular surgery.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

678  606  755  1977 

Top 10 Active Counters
 LRS 0.054+0.003 
 HNR 0.0120.00 
 DHR 0.0040.00 
 PWN 0.017+0.004 
 HWK 0.024-0.004 
 CWL 0.0370.00 
 RAG 0.0110.00 
 AUZ 0.030.00 
 ESH 0.018+0.001 
 ADV 0.026+0.003